Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $70.25 USD
Change Today -0.08 / -0.11%
Volume 561.7K
ALKS On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 08/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Floyd E. Bloom M.D.

Co-Founder, Director and Member of Audit & Risk Committee, Alkermes plc
AgeTotal Calculated CompensationThis person is connected to 93 board members in 9 different organizations across 6 different industries.

See Board Relationships
78$554,893

Background*

Dr. Floyd E. Bloom, M.D. is a Co-Founder of Alkermes Inc. Dr. Bloom served as the Chairman and Chief Executive Officer of Neurome Inc. Dr. Bloom has been active in Neuropharmacology for more than 35 years, holding positions at Yale University, the National Institute of Mental Health and The Salk Institute. He has investigated comprehensive eneurotransmitter systems at the anatomical, physiological, and pharmacological levels. Dr. Bloom has conducted correlative studies ...

Read Full Background

Corporate Headquarters*

Connaught House
Dublin, Co. Dublin 4

Ireland

Phone: 353 1 772 8000
Fax: --

Board Members Memberships*

1987-Present
Co-Founder, Director and Member of Audit & Risk Committee

Education*

BA
Southern Methodist University
MD
Washington University School of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$85,500
Total Calculated Compensation$554,893
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALKS:US $70.25 USD -0.08

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
David M. Stack Chairman, Chief Executive Officer and President
Pacira Pharmaceuticals, Inc.
$1.0M
Herve Hoppenot Chief Executive Officer, President, Director and Member of Non-Management Stock Option Committee
Incyte Corporation
$2.9M
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$620.1K
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$830.0K
Vinita Gupta Chief Executive Officer, Executive Director and Member of Risk Management Committee
Lupin Limited
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALKERMES PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.